Cargando…
Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases
BACKGROUND: Beneficial response to first-line immunosuppressive azathioprine in patients with inflammatory bowel disease (IBD) is low due to high rates of adverse events. Co-administrating allopurinol has been shown to improve tolerability. However, data on this co-therapy as first-line treatment ar...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287424/ https://www.ncbi.nlm.nih.gov/pubmed/34729677 http://dx.doi.org/10.1007/s10620-021-07273-y |